Probiotic supplements
BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7138 (Published 04 December 2013) Cite this as: BMJ 2013;347:f7138- David Andrew Osborn, associate professor,
- John K H Sinn, associate professor
- 1University of Sydney, Sydney, NSW 2065, Australia
- john.sinn{at}sydney.edu.au
Probiotics are live micro-organisms that, when given in adequate amounts, confer a health benefit to the recipient. Probiotics have been proposed for the prevention and treatment of allergic disorders. They usually contain Bifidobacterium or Lactobacillus spp, or both. These bacteria are delivered orally by a variety of methods including capsules; oil droplets; and suspensions in water, milk, or infant formula. They are not the same species as those found in yoghurt and are given at much higher doses. Evidence suggests that the use of probiotics during pregnancy or infancy may prevent eczema and IgE associated eczema in infants.1 However, in a linked systematic review of randomised controlled trials that evaluated probiotics given to mothers during pregnancy or to infants during the first year of life, Azad and colleagues (doi:10.1136/bmj.f6471) report no effect on asthma diagnosed by a physician or wheeze in young children.2 They conclude that probiotic supplements cannot be recommended for the primary prevention of asthma.
Azad and colleagues assessed 20 trials that enrolled 4866 infants, although not all studies reported outcomes, so individual analyses are limited to a subset of studies.2 The review is …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.